vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and JACK IN THE BOX INC (JACK). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $349.5M, roughly 1.4× JACK IN THE BOX INC). JACK IN THE BOX INC runs the higher net margin — -0.7% vs -10.1%, a 9.4% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs -25.5%). JACK IN THE BOX INC produced more free cash flow last quarter ($7.3M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs -18.6%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Jack in the Box, Inc. is an American fast food restaurant chain founded on February 21, 1951, by Robert O. Peterson in San Diego, California, where it is headquartered. The chain has over 2,200 locations, primarily serving the West Coast of the United States. Restaurants are also found in large urban areas outside the West Coast, as well as two in Guam. The company also formerly operated the Qdoba Mexican Grill chain until Apollo Global Management bought the chain in December 2017.

CLOV vs JACK — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.4× larger
CLOV
$487.7M
$349.5M
JACK
Growing faster (revenue YoY)
CLOV
CLOV
+70.3% gap
CLOV
44.7%
-25.5%
JACK
Higher net margin
JACK
JACK
9.4% more per $
JACK
-0.7%
-10.1%
CLOV
More free cash flow
JACK
JACK
$76.3M more FCF
JACK
$7.3M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
-18.6%
JACK

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CLOV
CLOV
JACK
JACK
Revenue
$487.7M
$349.5M
Net Profit
$-49.3M
$-2.5M
Gross Margin
Operating Margin
-10.1%
13.3%
Net Margin
-10.1%
-0.7%
Revenue YoY
44.7%
-25.5%
Net Profit YoY
-123.2%
-107.3%
EPS (diluted)
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
JACK
JACK
Q1 26
$349.5M
Q4 25
$487.7M
Q3 25
$496.6M
Q2 25
$477.6M
$336.7M
Q1 25
$462.3M
$371.1M
Q4 24
$337.0M
Q3 24
$331.0M
Q2 24
$356.3M
$365.3M
Net Profit
CLOV
CLOV
JACK
JACK
Q1 26
$-2.5M
Q4 25
$-49.3M
Q3 25
$-24.4M
Q2 25
$-10.6M
$-142.2M
Q1 25
$-1.3M
$33.7M
Q4 24
$-22.1M
Q3 24
$-9.2M
Q2 24
$7.4M
$25.0M
Gross Margin
CLOV
CLOV
JACK
JACK
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Operating Margin
CLOV
CLOV
JACK
JACK
Q1 26
13.3%
Q4 25
-10.1%
Q3 25
-4.9%
Q2 25
-2.2%
-46.7%
Q1 25
-0.3%
19.0%
Q4 24
-6.4%
Q3 24
-2.7%
Q2 24
2.0%
14.8%
Net Margin
CLOV
CLOV
JACK
JACK
Q1 26
-0.7%
Q4 25
-10.1%
Q3 25
-4.9%
Q2 25
-2.2%
-42.2%
Q1 25
-0.3%
9.1%
Q4 24
-6.6%
Q3 24
-2.8%
Q2 24
2.1%
6.8%
EPS (diluted)
CLOV
CLOV
JACK
JACK
Q1 26
$-0.13
Q4 25
Q3 25
Q2 25
$-7.47
Q1 25
$1.75
Q4 24
Q3 24
Q2 24
$1.26

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
JACK
JACK
Cash + ST InvestmentsLiquidity on hand
$78.3M
Total DebtLower is stronger
$1.6B
Stockholders' EquityBook value
$308.7M
$-936.0M
Total Assets
$541.0M
$2.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
JACK
JACK
Q1 26
Q4 25
$78.3M
Q3 25
Q2 25
Q1 25
Q4 24
$194.5M
Q3 24
$288.0M
Q2 24
$254.8M
Total Debt
CLOV
CLOV
JACK
JACK
Q1 26
$1.6B
Q4 25
Q3 25
Q2 25
$1.7B
Q1 25
$1.7B
Q4 24
Q3 24
Q2 24
$1.7B
Stockholders' Equity
CLOV
CLOV
JACK
JACK
Q1 26
$-936.0M
Q4 25
$308.7M
Q3 25
$340.9M
Q2 25
$344.2M
$-976.2M
Q1 25
$336.1M
$-827.1M
Q4 24
$341.1M
Q3 24
$342.2M
Q2 24
$324.9M
$-702.6M
Total Assets
CLOV
CLOV
JACK
JACK
Q1 26
$2.0B
Q4 25
$541.0M
Q3 25
$559.7M
Q2 25
$575.0M
$2.6B
Q1 25
$583.7M
$2.8B
Q4 24
$580.7M
Q3 24
$653.0M
Q2 24
$674.2M
$2.9B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
JACK
JACK
Operating Cash FlowLast quarter
$-66.9M
$30.5M
Free Cash FlowOCF − Capex
$-69.0M
$7.3M
FCF MarginFCF / Revenue
-14.1%
2.1%
Capex IntensityCapex / Revenue
0.4%
6.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$34.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
JACK
JACK
Q1 26
$30.5M
Q4 25
$-66.9M
Q3 25
$12.1M
Q2 25
$5.4M
$-36.8M
Q1 25
$-16.3M
$105.7M
Q4 24
$34.8M
Q3 24
$50.0M
Q2 24
$44.8M
$16.7M
Free Cash Flow
CLOV
CLOV
JACK
JACK
Q1 26
$7.3M
Q4 25
$-69.0M
Q3 25
$11.4M
Q2 25
$4.8M
$-63.2M
Q1 25
$-16.5M
$84.4M
Q4 24
$33.3M
Q3 24
$49.6M
Q2 24
$44.4M
$6.4M
FCF Margin
CLOV
CLOV
JACK
JACK
Q1 26
2.1%
Q4 25
-14.1%
Q3 25
2.3%
Q2 25
1.0%
-18.8%
Q1 25
-3.6%
22.7%
Q4 24
9.9%
Q3 24
15.0%
Q2 24
12.5%
1.8%
Capex Intensity
CLOV
CLOV
JACK
JACK
Q1 26
6.6%
Q4 25
0.4%
Q3 25
0.1%
Q2 25
0.1%
7.9%
Q1 25
0.0%
5.7%
Q4 24
0.5%
Q3 24
0.1%
Q2 24
0.1%
2.8%
Cash Conversion
CLOV
CLOV
JACK
JACK
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
3.14×
Q4 24
Q3 24
Q2 24
6.04×
0.67×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

JACK
JACK

Restaurant Sales$131.9M38%
Franchise$97.4M28%
Royaltyand Other$58.9M17%
Advertising$56.6M16%
Technology Service$4.7M1%
Franchise Fees$1.7M0%

Related Comparisons